Literature DB >> 12190866

Human keratinocytes express functional CD14 and toll-like receptor 4.

Peter I Song1, Young-Min Park, Tonya Abraham, Brad Harten, Adam Zivony, Natalia Neparidze, Cheryl A Armstrong, John C Ansel.   

Abstract

CD14 and the toll-like receptor 4 have been known to play an important role in lipopolysaccharide-induced cellular responses in bacterial infections. Although CD14 and toll-like receptor 4 expression has been demonstrated in a number of myeloid cells, much less is known about the expression and function of these lipopolysaccharide receptors on nonleukocytes. In this study, we demonstrate that human keratinocytes are capable of expressing functional CD14 and toll-like receptor 4. Keratinocytes were found to constitutively express CD14 and toll-like receptor 4 mRNA that was augmented by exposure to lipopolysaccharide. Cell surface expression of keratinocyte CD14 and toll-like receptor 4 was detected by flow cytometry. Lipopolysaccharide binding to keratinocyte CD14 and toll-like receptor 4 resulted in a rapid intracellular Ca2+ response, nuclear factor-kappaB nuclear translocation, and the secretion of proinflammatory cytokines and chemokines. These results have important implications for our understanding of cutaneous innate immunity to bacterial infections of the skin.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12190866     DOI: 10.1046/j.1523-1747.2002.01847.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  51 in total

Review 1.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

2.  Exposure to in utero lipopolysaccharide induces inflammation in the fetal ovine skin.

Authors:  Matthew W Kemp; Masatoshi Saito; Ilias Nitsos; Alan H Jobe; Suhas G Kallapur; John P Newnham
Journal:  Reprod Sci       Date:  2010-10-05       Impact factor: 3.060

3.  Effects of 15-deoxy-∆¹²,¹⁴-prostaglandin J₂ on the production of IL-8 and the expression of Toll-like receptor 2 in human primary keratinocytes stimulated with lipopolysaccharide.

Authors:  Young Il Kim; Jin-Woo Lee; Mu-Hyoung Lee; Seung-Won Park; Byung-Nam Cho; Ha Kyu Lee
Journal:  Mol Biol Rep       Date:  2010-02-21       Impact factor: 2.316

4.  Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.

Authors:  Gabriele Köllisch; Behnam Naderi Kalali; Verena Voelcker; Reinhard Wallich; Heidrun Behrendt; Johannes Ring; Stefan Bauer; Thilo Jakob; Martin Mempel; Markus Ollert
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

Review 5.  What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis.

Authors:  Marcus Maurer; Blaise Dondji; Esther von Stebut
Journal:  Med Microbiol Immunol       Date:  2009-04-25       Impact factor: 3.402

6.  Use of laser capture microdissection for the assessment of equine lamellar basal epithelial cell signalling in the early stages of laminitis.

Authors:  B S Leise; M R Watts; S Roy; A S Yilmaz; H Alder; J K Belknap
Journal:  Equine Vet J       Date:  2014-08-19       Impact factor: 2.888

7.  Lipopolysaccharide-squamous cell carcinoma-monocyte interactions induce cancer-supporting factors leading to rapid STAT3 activation.

Authors:  Zoya B Kurago; Aroonwan Lam-ubol; Anton Stetsenko; Chris De La Mater; Yiyi Chen; Deborah V Dawson
Journal:  Head Neck Pathol       Date:  2008-03

8.  Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma.

Authors:  Mirosław Szczepański; Witold Szyfter; Renata Jenek; Maciej Wróbel; Iwona Mozer Lisewska; Jan Zeromski
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-15       Impact factor: 2.503

9.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

10.  Toll-like receptors: role in dermatological disease.

Authors:  Aswin Hari; Tracy L Flach; Yan Shi; P Régine Mydlarski
Journal:  Mediators Inflamm       Date:  2010-08-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.